AI assistant
TherapeuticsMD, Inc. — Director's Dealing 2019
Oct 29, 2019
35134_dirs_2019-10-29_64c03a3c-d5d9-4841-adaf-89c56bacf4f7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2019-10-25
Reporting Person: Milligan John C.K. IV (Director, President/Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-10-25 | Common Stock | P | 72000 | $2.75 | Acquired | 1544419 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3582373 | Indirect |
| Common Stock | 434814 | Indirect |
Footnotes
F1: Represents a purchase from the underwriters in the issuer's public offering.
F2: Shares are owned by John C.K. Milligan Revocable Trust U/A 08/10/2009, as amended.
F3: Shares are owned by the Milligan Irrevocable Nonexempt Trust - 2014. These securities are held in a trust for the benefit of the reporting person's spouse and children. The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.